Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-011431
Filing Date
2025-04-08
Accepted
2025-04-08 17:01:26
Documents
125
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tlry20250228_10q.htm   iXBRL 10-Q 3252360
2 EXHIBIT 31.1 ex_767896.htm EX-31.1 13559
3 EXHIBIT 31.2 ex_767897.htm EX-31.2 13746
4 EXHIBIT 32.1 ex_767898.htm EX-32.1 5588
5 EXHIBIT 32.2 ex_767899.htm EX-32.2 6075
  Complete submission text file 0001437749-25-011431.txt   14067199

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tlry-20250228.xsd EX-101.SCH 117535
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlry-20250228_cal.xml EX-101.CAL 92756
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlry-20250228_def.xml EX-101.DEF 810903
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20250228_lab.xml EX-101.LAB 592382
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20250228_pre.xml EX-101.PRE 855225
128 EXTRACTED XBRL INSTANCE DOCUMENT tlry20250228_10q_htm.xml XML 2549476
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-38594 | Film No.: 25822701
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)